Among brokerages, CLSA and Jefferies have raised the target prices on Axis Bank while Citi maintains 'Buy' rating on HUL and has raised revenue forecasts by 1-2%. Here are the top brokerage calls for today.
JP Morgan on Axis Bank | The brokerage cut FY21 EPS for Axis Bank by 14% but kept FY22/23 largely unchanged after the bank’s Q3 results.
Macquarie on Axis Bank | Biggest positive from Axis Bank’s Q3 earnings review is the strengthening of the balance sheet by making provisions, Macquarie said. IT raised earnings estimates by 8-12% for FY22-23.
Citi on Axis Bank | Low restructuring and high provision buffer should imply lower credit costs for Axis Bank in FY22, Citi said.
Jefferies on Axis Bank | The bank’s Q3 profit was below estimates due to higher credit cost; growth in core operating profit & CASA was healthy, Jefferies says. The brokerage maintained 'Buy' on the stock and raised the target price to Rs 840 per share.
CLSA on Axis Bank | CLSA lifts its FY22-23 earnings estimates or Axis Bank by 5-12 percent, says an improvement in underwriting in last 4-5 years should lead to a big rerating for the bank. CLSA also raised the target price to Rs 1,000 per share.
Bernstein on Axis Bank | Higher provisions kept Axis Bank’s headline numbers weak, Bernstein says.
Citi on HUL | Citi maintains 'Buy' rating on HUL and has raised revenue forecasts by 1-2 percent.
Jefferies on HUL | Pick-up in personal care is positive, while the muted trend in the laundry is a disappointment, Jefferies said.
CLSA on HUL | CLSA continues to see HUL as a structural play in Indian FMCG after the company announced its Q3 earnings.
JP Morgan on HUL | The brokerage maintained 'Overweight' on HUL. It plans to add the stock if there’s any pullback.
CLSA on Bank of Baroda | The bank has delivered a surprise on asset quality; it sounds cautious on retail/MSME, CLSA said. It maintained an 'Outperform' rating and raised the target price to Rs 80 per share.
CLSA on Emami | Decent Q3 by Emami but there are tailwinds in the price, CLSA said. It has downgraded the stock due to limited upside.
CLSA on ICICI Prudential | CLSA expects APE trends for the company to improve in FY22, driven by a lower ULIP base.
CLSA on Nippon Life AMC | The brokerage has downgraded the stock to 'Outperform' from 'Buy' but raised the target price to Rs 340 per share.